Author

Ian E. Krop

Dana-Farber Cancer InstituteORCID 0000-0002-6380-5944Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1 Assay:proteomics· 1

Frequent Co-Authors

Sara M. TolaneyiD· 2 shared Adrienne Gropper WaksiD· 1 shared Ashka Patel· 1 shared Atish Dipankar ChoudhuryiD· 1 shared Austin Schultz· 1 shared Carlos Wagner S WanderleyiD· 1 shared Daniel G. StoveriD· 1 shared Douglas SheaiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Sara M. TolaneyORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Spatial/molecular heterogeneity and treatment response in HER2+ early breast cancer: Translational analyses from the DAPHNe trial

Emily Chen, Ilana Miriam Schlam, Kaoru Shimada, Tianyu Li, Esther Ritah Ogayo, Ashka Patel, Janae Davis, Jia‐Ren Lin, Austin Schultz, Madeline G Townsend, Kelly F Zheng, Carlos Wagner S Wanderley, Ricardo Pastorello, Felicia New, Evelyn Metzger, , Adrienne Gropper Waks

The paper analyzes HER2+ breast cancer using multi-platform data to identify molecular predictors of response to neoadjuvant therapy and highlights intra-tumoral heterogeneity and immune exclusion mechanisms.

bioRxiv · Sep 18, 2026 · PreprintCancer Biology

MAESTRO affords 'breadth and depth' for mutation testing

Gregory Gydush, Erica Nguyen, Jin H. Bae, Justin Rhoades, Sarah C. Reed, Douglas Shea, Kan Xiong, Ruolin Liu, Timothy Blewett, Fangyan Yu, Ka Wai Leong, Atish Dipankar Choudhury, Daniel G. Stover, Sara M. Tolaney, Ian E. Krop, , Viktor A. Adalsteinsson

MAESTRO enables efficient and accurate tracking of thousands of low-frequency mutations with reduced sequencing, improving mutation testing in cancer and liquid biopsies.

bioRxiv · Jan 22, 2021 · PreprintMolecular Biology